Differential availability/processing of decorin precursor in arterial and venous smooth muscle cells

Journal of Anatomy

Volumn 209, Issue 3, 2006, Pages 271-287

  Franch, Rafaella ^a   Chiavegato, Angela ^a   Maraschin, Maddalena ^a   Candeo, Serena ^a   Ausoni, Simonetta ^a,b   Villa, Antonello ^c   Gerosa, Gino ^a   Gasparotto, Lisa ^a   Parnigotto, Pierpaolo ^a   Sartore, Saverio ^a,b  

^a UNIVERSITY OF PADOVA   (Italy)

^b NRC Institute of Neuroscience   (Italy)

^c UNIVERSITY OF MILAN   (Italy)

Author keywords

Arteries; Differentiation; Extracellular matrix proteins; Smooth muscle cells; Veins

Indexed keywords

CHONDROITIN ABC LYASE; DECORIN; MONOCLONAL ANTIBODY MM1; MONOMER; POLYPEPTIDE; PROTEIN PRECURSOR; PROTEOGLYCAN;

ANIMAL CELL; ANIMAL TISSUE; AORTA; ARTICLE; BLOOD VESSEL GRAFT; CAROTID ARTERY; CELL CULTURE; CELL DIFFERENTIATION; CELL ISOLATION; CELL PROLIFERATION; CONTROLLED STUDY; CULTURE MEDIUM; DOT HYBRIDIZATION; ENDOTHELIUM LESION; FEMALE; FETUS; HYBRIDOMA; IMMUNOASSAY; IMMUNOCYTOCHEMISTRY; IMMUNOPRECIPITATION; IMMUNOREACTIVITY; IN VITRO STUDY; IN VIVO STUDY; INTIMA; LUNG VEIN; MASS SPECTROMETRY; MOLECULAR CLONING; MOLECULAR WEIGHT; MOUSE; NEWBORN; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; SMOOTH MUSCLE FIBER; SWINE; UPREGULATION; VASCULAR SMOOTH MUSCLE; VEIN INJURY; WESTERN BLOTTING;

ANIMALS; ANIMALS, NEWBORN; ANTIBODIES, MONOCLONAL; ANTIBODY SPECIFICITY; ANTIGEN-ANTIBODY REACTIONS; AORTA; BLOOD VESSEL PROSTHESIS IMPLANTATION; BLOTTING, WESTERN; CELLS, CULTURED; CORONARY VESSELS; DECORIN; EXTRACELLULAR MATRIX PROTEINS; FEMALE; HUMANS; HYBRIDOMAS; IMMUNOPRECIPITATION; JUGULAR VEINS; MICE; MICE, INBRED BALB C; MICROSCOPY, CONFOCAL; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; PROTEOGLYCANS; PULMONARY VEINS; SWINE;

SUIDAE;

EID: 33747682244     PISSN: 00218782     EISSN: 14697580     Source Type: Journal    
DOI: 10.1111/j.1469-7580.2006.00614.x     Document Type: Article

References (52)

1. Adams LD, Geary RL, McManus B, Schwartz SM (2000) A comparison of aorta and vena cava medial message expression by cDNA array analysis identifies a set of 68 consistently differentially expressed genes, all in aortic media. Circ Res 87, 623-631.
2. Adams RH, Wilkinson GA, Weiss C, et al. (1999) Roles of ephrin B ligands and EphB receptors in cardiovascular developments: Demarcation of arterial/venous domains, vascular morphogenesis, and sprouting angiogenesis. Genes Dev 13, 295-306.
3. Adams RH (2003) Molecular control of arterial-venous blood vessel identity. J Anat 202, 105-112.
4. Ausoni S, Sartore S (2001) Cell lineages and tissue boundaries in cardiac arterial and venous poles. Arterioscler Thromb Vasc Biol 21, 312-320.
5. Borrione A, Zanellato AC, Scannapieco G, Pauletto P, Sartore S (1989) Myosin heavy-chain isoforms in adult and developing rabbit vascular smooth muscle. Eur J Biochem 183, 413-417.
6. Chiavegato A, Roelofs M, Franch R, Castellucci E, Sarinella F, Sartore S (1999) Differential expression of SM22 isoforms in myofibroblasts and smooth muscle cells from rabbit bladder. J Muscle Res Cell Motil 20, 133-146.
7. Conway EM, Collen D, Carmerliet P (2001) Molecular mechanisms of blood vessel growth. Cardiovasc Res 49, 507-521.
8. Crippes Trask B, Trask TM, Broekelmann T, Mecham RP (2000) The microfibrillar proteins MAGP-1 and fibrillin-1 form a ternary complex with the chondroitin sulfate proteoglycan decorin. Matrix Biol 11, 1499-1507.
9. Day AA, McQuillan CI, Termine JD, Young MR (1987) Molecular cloning and sequence analysis of the cDNA for small proteoglycan II of bovine bone. Biochem J 248, 801-805.
10. Fischer JW, Kinsella MG, Clowes MM, Lara S, Clowes AW, Wight TN (2000) Local expression of bovine decorin by cell-mediated gene transfer reduces neointimal formation after balloon injury in rats. Circ Res 86, 676-683.
11. Fischer JW, Kinsella MG, Levkau B, Clowes AW, Wight TN (2001) Retroviral overexpression of decorin differentially affects the response of arterial smooth muscle cells to growth factors. Arterioscler Thromb Vasc Biol 21, 777-784.
12. Gale NW, Baluk P, Pan L, et al. (2001) Ephrin-B2 selectively marks arterial vessels and neovascularization sites in the adult, with expression in both endothelial and smooth-muscle cells. Dev Biol 230, 151-160.
13. Grönroos A, Pirkonen P, Ruppert O (2004) Ultrasonic depolymerization of aqueous carboxymethylcellulose. Ultrason Sonochem 11, 9-12.
14. Groves PH, Banning AP, Penny WJ, Lewis MJ, Cheadle HA, Newby AC (1995) Kinetics of smooth muscle cell proliferation and intimal thickening in a pig carotid model of balloon injury. Atherosclerosis 117, 83-96.
15. Guyton AC, Hall JE (1996) Handbook of Physiology. Philadelphia: W.B. Saunders Co.
16. Helbling PM, Saulnier DME, Brandli AW (2000) The receptor tyrosine EphB4 and ephrin-B ligands restrict angiogenic growth of embryonic veins in Xenopus laevis. Development 127, 269-278.
17. Hellström M, Mattsson C, Hellström S, Engström-Laurent A (2003) Hyaluronan is differently located in arteries and veins. Cells Tissues Organs 173, 227-233.
18. Hsieh C-M, Yoshizumi M, Endege WO, et al. (1996) APEG-1, a novel gene preferentially expressed in aortic smooth muscle cells, is down-regulated by vascular injury. J Biol Chem 271, 17354-17359.
19. Hungerford JE, Little CD (1999) Developmental biology of the vascular smooth muscle cell: Building a multilayered vessel wall. J Vasc Res 36, 2-27.
20. Järveläinen HT, Kinsella MG, Wight TN, Sandell LJ (1991) Differential expression of small chondroitin/dermatan sulfate proteoglycans, PG-I/biglycan and PG-II/decorin, by vascular smooth muscle and endothelial cells in culture. J Biol Chem 266, 23274-23281.
21. Järveläinen H, Vernon RB, Gooden MD, et al. (2004) Overexpression of decorin by rat arterial smooth muscle cells enhances contraction of type I collagen in vitro. Arterioscler Thromb Vasc Biol 24, 67-72.
22. Johnstone B, Markopoulos M, Neame P, Caterson B (1993) Identification and characterization of glycanated and non-glycanated forms of biglycan and decorin in the human intervertebral disc. Biochem J 292, 661-666.
23. Kim S-J, Masaki T, Leypoldt JK, Kamerath CD, Mohammad SF, Cheung AK (2004) Arterial and venous smooth-muscle cells differ in their responses to antiproliferative drugs. J Lab Clin Med 144, 156-162.
24. Lawson ND, Weinstein BM (2002) Arteries and veins: Making a difference with zebrafish. Nature Rev Genet 3, 674-682.
25. Li L, Miano JM, Mercer B, Olson EN (1996) Expression of the SM22α promoter in transgenic mice provides evidence for distinct transcriptional regulatory programs in vascular and visceral smooth muscle cells. J Cell Biol 132, 849-859.
26. Loughna S, Sato TN (2001) A combinatorial role of angiopoietin-1 and orphan receptor TIE1 pathways in establishing vascular polarity during angiogenesis. Mol Cell 7, 233-239.
27. Murfee WL, Skalak TC, Peirce SM (2005) Differential arterial/venous expression of NG2 proteoglycan in perivascular cells along microvessels: identifying a venule specific phenotype. Microcirculation 12, 151-160.
28. Newby AC, George SJ (1996) Proliferation, migration, matrix turnover, and death of smooth muscle cells in native coronary and vein graft atherosclerosis. Curr Opin Cardiol 11, 574-582.
29. Nili N, Cheema AN, Giordano FJ, et al. (2003) Decorin inhibition of PSGF-stimulated vascular smooth muscle cell function: Potential mechanism for inhibition of intimal hyperplasia after balloon angioplasty. Am J Pathol 163, 869-878.
30. Okai-Matsuo Y, Takano-Ohmuro H, Toyo-oka T (1991) A novel myosin heavy chain isoform in vascular smooth muscle. Biochem Biophys Res Commun 176, 1365-1370.
31. Ratajska A, Zarska M, Quensel C, Kramer J (2001) Differentiation of the smooth muscle cell phenotypes during embryonic development of coronary vessels in the rat. Histochem Cell Biol 116, 79-87.
32. Reinboth B, Hanssen E, Cleary EG, Gibson MA (2002) Molecular interactions of biglycan and decorin with elastic fiber components. J Biol Chem 277, 3950-3957.
33. Ross R (1993) The patogenesis of atherosclerosis: A perspective for the 1990s. Nature 362, 801-809.
34. Sartore S, Franch R, Roelofs M, Chiavegato A (1999) Molecular and cellular phenotypes and their regulation in smooth muscle. Rev Physiol Biochem Pharmacol 134, 235-320.
35. Sawada H, Shinomura T, Kimata K, Takeuchi J, Tsuji T, Watanabe H (2002) Characterization of an anti-decorin monoclonal antibody, and its utility. J Biochem 132, 997-1002.
36. Sawhney R, Hering TM, Sandell LJ (1991) Biosynthesis of small proteoglycan II (decorin) by chondrocytes and evidence for a procure protein. J Biol Chem 266, 9321-9240.
37. Scott PG, Dodd CM, Pringle GA (1993) Mapping the locations of the epitopes of five monoclonal antibodies to the core protein of dermatan sulfate proteoglycan II (decorin). J Biol Chem 268, 11558-11564.
38. Scott PG, Grossmann JG, Dodd CM, Sheehan JK, Bishop PN (2003) Light and x-ray scattering show decorin to be a dimer in solution. J Biol Chem 278, 18353-18359.
39. Scott PG, McEwan PA, Dodd CM, Bergmann EM, Bishop PN, Bella J (2004) Crystal structure of the dimeric protein core of decorin, the archetypal small leucine-rich repeat proteoglycan. Proc Natl Acad Sci USA 101, 15633-15638.
40. Shin D, Garcia-Cardena G, Hayashi S-I, et al. (2001) Expression of ephrinB2 identifies a stable genetic difference between arterial and venous vascular smooth muscle as well as endothelial cells, and marks subsets of microvessels at sites of adult neovascularization. Dev Biol 230, 139-150.
41. Sorrell JM, Carrino DA, Baber MA, Asselineau D, Caplan AI (1999) A monoclonal antibody which recognizes a glycosaminoglycan epitope in both dermatan sulfate and chondroitin sulfate proteoglycans of human skin. Histochem J 31, 549-588.
42. Ulrich-Merzenich G, Metzner C, Bhonde RR, Malsch G, Schiermeyer B, Vetter H (2002) Simulatenous isolation of endothelial and smooth muscle cells from human umbilical artery or vein and their growth response to low-density lipoproteins. In Vitro Cell Dev Biol 38, 265-272.
43. Urness LD, Sorensen LK, Li DY (2000) Arteriovenous malformations in mice lacking activin receptor-like kinase-1. Nature Genet 26, 328-331.
44. Van der Loop FT, Gabbiani G, Kohnen G, Ramaekers FC, Van Eys GJ (1997) Differentiation of smooth muscle cells in human blood vessels as defined by smoothelin, a novel marker for the contractile phenotype. Arterioscler Thromb Vasc Biol 17, 665-671.
45. Wallner K, Li C, Fishbein MC, Shah PK, Sharifi BG (1999) Arterialization of human vein graft is associated with tenascin-C expression. J Am Coll Cardiol 34, 871-875.
46. Wang HU, Chen Z-F, Anderson DJ (1998) Molecular distinction and angiogenic interaction between embryonic arteries and veins revealed by ephrin-B2 and its receptor Eph-B4. Cell 93, 741-753.
47. Wheatley DN, Graham E, McMaster RS, Muir IFK, Holmes JD, Davies M (2004) Recovery of the decorin-enriched fraction, extract (D), from human skin: an accelerated protocol. J Biom Biotechn 4, 211-218.
48. Wong AP, Nili N, Strauss BH (2005) In vitro differences between venous and arterial-derived smooth muscle cells: Potential modulatory role of decorin. Cardiovasc Res 65, 702-710.
49. Yamakawa T, Bai H-Z, Masuda J, et al. (2000) Differential expression of proteoglycans biglycan and decorin during neointima formation after stent implantation in normal and atherosclerotic rabbit aortas. Atherosclerosis 152, 287-298.
50. Yancopoulos GD, Davis S, Gale NW, Rudge JS, Wiegand SJ, Holash J (2000) Vascular-specific growth factors and blood formation. Nature 407, 242-248.
51. Yang Z, Oemar BS, Carrel T, Kipfer B, Julmy F, Lüscher TF (1998) Different proliferative properties of smooth muscle cells of human arterial and venous bypass vessels. Circulation 97, 181-187.
52. Zhang W-D, Bai H-Z, Sawa Y, et al. (1999) Association of smooth muscle cell phenotypic modulation with extracellular matrix alterations during neointima formation in rabbit vein grafts. J Vasc Surg 30, 169-183.